BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21585625)

  • 1. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda.
    Elbireer S; Guwatudde D; Mudiope P; Nabbuye-Sekandi J; Manabe YC
    Trop Med Int Health; 2011 Aug; 16(8):981-7. PubMed ID: 21585625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana.
    Burton NT; Forson A; Lurie MN; Kudzawu S; Kwarteng E; Kwara A
    Trans R Soc Trop Med Hyg; 2011 Dec; 105(12):675-82. PubMed ID: 21920570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing completion of treatment among tuberculosis patients in Mbarara District, Uganda.
    Nuwaha F
    East Afr Med J; 1997 Nov; 74(11):690-3. PubMed ID: 9557437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting defaulting from DOTS therapy under the national programme of tuberculosis control in Alexandria, Egypt.
    El-Din MN; Elhoseeny T; Mohsen AM
    East Mediterr Health J; 2013 Feb; 19(2):107-13. PubMed ID: 23516818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.
    Kumwenda M; Tom S; Chan AK; Mwinjiwa E; Sodhi S; Joshua M; van Lettow M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1663-9. PubMed ID: 22118175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative study of perceived causes of tuberculosis treatment default among health care workers in Morocco.
    Kizub D; Ghali I; Sabouni R; Bourkadi JE; Bennani K; El Aouad R; Dooley KE
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1214-20. PubMed ID: 22793783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of increasing incentives on adherence to tuberculosis directly observed therapy.
    Davidson H; Schluger NW; Feldman PH; Valentine DP; Telzak EE; Laufer FN
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):860-5. PubMed ID: 10985655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic review: tuberculosis.
    Houston S; Pozniak A; Ray CS
    Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with tuberculosis treatment default among HIV-infected tuberculosis patients in Thailand.
    Kittikraisak W; Burapat C; Kaewsa-ard S; Watthanaamornkiet W; Sirinak C; Sattayawuthipong W; Jittimanee S; Pobkeeree V; Varma JK
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):59-66. PubMed ID: 18937958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
    Ifebunandu NA; Ukwaja KN; Obi SN
    Trop Doct; 2012 Apr; 42(2):74-6. PubMed ID: 22431822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of treatment failure among tuberculosis patients under DOTS strategy in Egypt.
    Morsy AM; Zaher HH; Hassan MH; Shouman A
    East Mediterr Health J; 2003 Jul; 9(4):689-701. PubMed ID: 15748066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research and control of relapse tuberculosis cases].
    Yamagishi F; Toyota M
    Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.
    Kumar A; Kumar AM; Gupta D; Kanchar A; Mohammed S; Srinath S; Tripathy S; Rajasekaran S; Chan PL; Swaminathan S; Dewan PK
    Int J Tuberc Lung Dis; 2012 May; 16(5):573-8. PubMed ID: 22507931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with human immunodeficiency virus testing among tuberculosis patients receiving treatment at health facilities in Uganda.
    Nabbuye-Sekandi J; Okot-Chono R; Rusen ID; Dlodlo RA; Katamba A; Tumwesigye NM; Fujiwara PI
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):896-902. PubMed ID: 20550775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients.
    Naing NN; D'Este C; Isa AR; Salleh R; Bakar N; Mahmod MR
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):369-82. PubMed ID: 11556591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal.
    Bam TS; Gunneberg C; Chamroonsawasdi K; Bam DS; Aalberg O; Kasland O; Shiyalap K; Srisorrachatr S
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):270-6. PubMed ID: 16562706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of pulmonary tuberculosis treatment in the tertiary care setting--Toronto 1992/93. Tuberculosis Treatment Completion Study Group.
    Wobeser W; Yuan L; Naus M
    CMAJ; 1999 Mar; 160(6):789-94. PubMed ID: 10189422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.